Large-scale testing (Phase 3)Looking for participantsNCT07555483
What this trial is testing
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Who this might be right for
Alpha 1 Antitrypsin Deficiency
Grifols Therapeutics LLC 40